Form 8-K - Current report:
SEC Accession No. 0000950123-10-091452
Filing Date
2010-10-05
Accepted
2010-10-05 17:16:12
Documents
6
Period of Report
2010-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c06485e8vk.htm 8-K 13251
2 EXHIBIT 10.16.1 c06485exv10w16w1.htm EX-10.16.1 41751
3 EXHIBIT 99.1 c06485exv99w1.htm EX-99.1 27354
4 EXHIBIT 99.2 c06485exv99w2.htm EX-99.2 28634
5 EXHIBIT 99.3 c06485exv99w3.htm EX-99.3 6902
6 GRAPHIC c06485p0648501.jpg GRAPHIC 22570
  Complete submission text file 0000950123-10-091452.txt   150805
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 101109994
SIC: 2834 Pharmaceutical Preparations